NCT01861548

Brief Summary

The Polish Mother and Child Cohort is multicentre prospective study on different exposures. Prospective cohort study design enables identification of exposures that may influence pregnancy outcome and chil-dren's health, verification of such exposures by biomarker measurements and notification of any changes in exposure levels. The aim of the study is to evaluate the impact of exposure to different environmental factors during pregnancy and after birth on pregnancy outcome and children's health. Specific research hypotheses refer to the role of heavy metals, exposure to polycyclic aromatic hydrocar-bons (PAHs) and environmental tobacco smoke (ETS) in the aetiology of intrauterine growth retardation (IUGR), preterm delivery (PD) and the risk of respiratory diseases, allergy and poor mental and physical development. It is also intended to explain the role of oxidative stress and nutritional status of the pregnant women. The impact of occupational exposures and stressful situations on pregnancy outcome will be evaluated from question-naire data. The results of the study will help to determine levels of child prenatal and postnatal exposure in several areas of Poland and their im-pact on course and outcome of pregnancy and children's health. This protocol concerns the children that are followed-up from birth to the age of 2 years to determine long term effects of pre- and postnatal environmental exposures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
479

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 23, 2013

Completed
Last Updated

May 23, 2013

Status Verified

May 1, 2013

Enrollment Period

6.3 years

First QC Date

May 17, 2013

Last Update Submit

May 21, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Exposure of children to Environmental tobacco smoke(ETS)

    Postnatal children exposure to ETS at 12, and 24 months after birth is assessed. From the children urine sample and saliva samples from mothers who will declare smoking abstinence are collected. The saliva and urine cotinine level is analysed using high performance liquid chromatography coupled with tandem mass spectrometry/positive electrospray ionization (LC-ESI+MS/MS) and isotope dilution.

    Change from baseline of exposure of children to environmental tobacco smoke at 12 months

Secondary Outcomes (6)

  • Exposure of children to polycyclic aromatic hydrocarbons (PAH)

    Change from baseline of exposure of children to polycyclic aromatic hydrocarbons at 12 months

  • Exposure to lead, cadmium, mercury in children.

    Change from baseline of exposure to lead, cadmium, mercury in children at 12 months.

  • Exposure to indoor allergens, endotoxins and glucans in children.

    Change from baseline of exposure to indoor allergens, endotoxins and glucans in children at 12 months.

  • Questionnaires conducted with mothers.

    Change from baseline of questionnaires scores at 12 months.

  • Determination of the prevalence of the upper and lower respiratory tract infections, middle ear diseases and allergy among the child.

    Change from baseline of the prevalence of infections and allergies at 12 months

  • +1 more secondary outcomes

Study Arms (1)

Children (up to 24 months after birth)

Investigators include into the study children delivered from women observed starting from between 8-12 weeks of single pregnancy, not assisted with reproductive technology, and not expected to be finished as spontaneous abor-tion. All women with the serious chronic diseases specified in study protocol such as diabetes, hypertension, nephrop-athy, epilepsy and cancer are excluded from the study. The same refers to suspicion of serious child malformations known to exist at the inclusion into the study.

Eligibility Criteria

Age1 Minute - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Investigators include into the study children delivered from women observed starting from between 8-12 weeks of single pregnancy, not assisted with reproductive technology, and not expected to be finished as spontaneous abor-tion. All women with the serious chronic diseases specified in study protocol such as diabetes, hypertension, nephrop-athy, epilepsy and cancer are excluded from the study. The same refers to suspicion of serious child malformations known to exist at the inclusion into the study.

You may not qualify if:

  • Children delivered from all women with the serious chronic diseases specified in study protocol such as diabetes, hypertension, nephrop-athy, epilepsy and cancer are excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology

Lodz, 91-348, Poland

Location

Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

Lodz, 93-513, Poland

Location

Related Publications (3)

  • Podlecka D, Jerzynska J, Sanad K, Polanska K, Bobrowska-Korzeniowska M, Stelmach I, Brzozowska A. Micronutrients and the Risk of Allergic Diseases in School Children. Int J Environ Res Public Health. 2022 Sep 26;19(19):12187. doi: 10.3390/ijerph191912187.

  • Stelmach I, Bobrowska-Korzeniowska M, Smejda K, Majak P, Jerzynska J, Stelmach W, Polanska K, Sobala W, Krysicka J, Hanke W. Risk factors for the development of atopic dermatitis and early wheeze. Allergy Asthma Proc. 2014 Sep-Oct;35(5):382-9. doi: 10.2500/aap.2014.35.3786.

  • Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, Kopka M, Majak P, Jerzynska J, Stelmach W, Polanska K, Sobala W, Gromadzinska J, Wasowicz W, Hanke W. The role of zinc, copper, plasma glutathione peroxidase enzyme, and vitamins in the development of allergic diseases in early childhood: The Polish mother and child cohort study. Allergy Asthma Proc. 2014 May-Jun;35(3):227-32. doi: 10.2500/aap.2014.35.3748.

Biospecimen

Retention: SAMPLES WITH DNA

blood, urine, hair, saliva

MeSH Terms

Conditions

AsthmaDermatitis, AtopicFood HypersensitivityRespiratory Sounds

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSkin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, EczematousSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Iwona Stelmach, MD,PhD,Prof.

    Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

    PRINCIPAL INVESTIGATOR
  • Monika Kopka, MD

    Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

    PRINCIPAL INVESTIGATOR
  • Wojciech Hanke, MD,PhD,Prof.

    Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology

    PRINCIPAL INVESTIGATOR
  • Kinga Polanska, MD, PhD

    Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Prof.

Study Record Dates

First Submitted

May 17, 2013

First Posted

May 23, 2013

Study Start

January 1, 2007

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

May 23, 2013

Record last verified: 2013-05

Locations